Media-OutReach Newswire Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
Media-OutReach Newswire Rethinking Obesity: Novo Nordisk’s Latest Initiative Urges Singaporeans to Treat, Not Blame
Media-OutReach Newswire Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire HKSTP Leads Unprecedented Delegation of 25 Hong Kong Tech Ventures to Tap Fast-Growing Middle East Market at Saudi Arabia's FII8
Media-OutReach Newswire Securities Firms Bullish on Fosun's Growth Path: Boosting Profits, Reducing Leverage
Media-OutReach Newswire ZJLD Group Reported Robust Interim Results of RMB4.1 Billion Revenue for FY2024